Aggregatibacter actinomycetemcomitans Infection Enhances Apoptosis In Vivo through a Caspase-3-Dependent Mechanism in Experimental Periodontitis

ABSTRACT The purpose of this study was to test the hypothesis that diabetes aggravates periodontal destruction induced by Aggregatibacter actinomycetemcomitans infection. Thirty-eight diabetic and 33 normal rats were inoculated with A. actinomycetemcomitans and euthanized at baseline and at 4, 5, and 6 weeks after inoculation. Bone loss and the infiltration of polymorphonuclear leukocytes (PMNs) in gingival epithelium were measured in hematoxylin-eosin-stained sections. The induction of tumor necrosis factor alpha (TNF-α) was evaluated by immunohistochemistry and of apoptotic cells by a TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) assay. After A. actinomycetemcomitans infection, the bone loss in diabetic rats was 1.7-fold and the PMN infiltration 1.6-fold higher than in normoglycemic rats (P < 0.05). The induction of TNF-α was 1.5-fold higher and of apoptotic cells was up to 3-fold higher in diabetic versus normoglycemic rats (P < 0.05). Treatment with a caspase-3 inhibitor significantly blocked noninflammatory cell apoptosis induced by A. actinomycetemcomitans infection in gingival epithelium and connective tissue (P < 0.05). These results provide new insight into how diabetes aggravates A. actinomycetemcomitans-induced periodontal destruction in rats by significantly increasing the inflammatory response, leading to increased bone loss and enhancing apoptosis of gingival epithelial and connective tissue cells through a caspase-3-dependent mechanism. Antibiotics had a more pronounced effect on many of these parameters in diabetic than in normoglycemic rats, suggesting a deficiency in the capacity of diabetic animals to resist infection.

[1]  S. Bloom,et al.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. , 2011, Microbiology.

[2]  Panos N. Papapanou,et al.  Diabetes mellitus and periodontitis: a tale of two common interrelated diseases , 2011, Nature Reviews Endocrinology.

[3]  D. Graves,et al.  Interaction of oral bacteria with gingival epithelial cell multilayers. , 2011, Molecular oral microbiology.

[4]  E. Feres-Filho,et al.  Impact of systemic antimicrobials combined with anti-infective mechanical debridement on the microbiota of generalized aggressive periodontitis: a 6-month RCT. , 2011, Journal of clinical periodontology.

[5]  Hyunjin Shin,et al.  State of the union between metabolism and the immune system in type 2 diabetes , 2011, Genes and Immunity.

[6]  T. Takata,et al.  Topical application of Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces cell cycle arrest in the rat gingival epithelium in vivo. , 2011, Journal of periodontal research.

[7]  D. Graves,et al.  Inflammation and Uncoupling as Mechanisms of Periodontal Bone Loss , 2011, Journal of dental research.

[8]  Y. Li,et al.  Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. , 2010, Molecular oral microbiology.

[9]  H. Baker,et al.  Role of the ATM-Checkpoint Kinase 2 Pathway in CDT-Mediated Apoptosis of Gingival Epithelial Cells , 2010, PloS one.

[10]  H. Issever,et al.  Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. , 2010, Journal of periodontology.

[11]  G. Armitage,et al.  Comparison of the clinical features of chronic and aggressive periodontitis. , 2010, Periodontology 2000.

[12]  W. Borgnakke,et al.  The relationship between oral health and diabetes mellitus. , 2008, Journal of the American Dental Association.

[13]  M. Kilian,et al.  Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study , 2008, The Lancet.

[14]  D. Fine,et al.  Aggregatibacter actinomycetemcomitans and Its Relationship to Initiation of Localized Aggressive Periodontitis: Longitudinal Cohort Study of Initially Healthy Adolescents , 2007, Journal of Clinical Microbiology.

[15]  D. Graves,et al.  Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. , 2007, Periodontology 2000.

[16]  J. Cirelli,et al.  Novel host response therapeutic approaches to treat periodontal diseases. , 2007, Periodontology 2000.

[17]  D. Graves,et al.  Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation , 2006, Journal of dental research.

[18]  D. Sakellari,et al.  Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. , 2006, Journal of clinical periodontology.

[19]  J. Penninger,et al.  G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. , 2005, Diabetes.

[20]  E. Krall,et al.  Inflammation is More Persistent in Type 1 Diabetic Mice , 2005, Journal of dental research.

[21]  T. Nishihara,et al.  Actinobacillus actinomycetemcomitans induces apoptosis in human monocytic THP-1 cells. , 2005, Journal of medical microbiology.

[22]  D. Graves,et al.  Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. , 2004, The Journal of investigative dermatology.

[23]  T. Nishihara,et al.  Involvement of caspase activation through release of cytochrome c from mitochondria in apoptotic cell death of macrophages infected with Actinobacillus actinomycetemcomitans. , 2004, FEMS microbiology letters.

[24]  D. Graves,et al.  Lipopolysaccharides Indirectly Stimulate Apoptosis and Global Induction of Apoptotic Genes in Fibroblasts* , 2003, Journal of Biological Chemistry.

[25]  D. Fine,et al.  Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Fine,et al.  Lactoferrin iron levels affect attachment of Actinobacillus actinomycetemcomitans to buccal epithelial cells. , 2002, Journal of periodontology.

[27]  D. Fine,et al.  Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats. , 2001, Archives of oral biology.

[28]  D. Graves,et al.  Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection , 2001, Journal of dental research.

[29]  P. Auron,et al.  CONCISE REVIEW Biological: Interleukin 1 Signal Transduction— Current Concepts and Relevance to Periodontitis , 2001, Journal of dental research.

[30]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[31]  K. Kojima,et al.  Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease , 1999 .

[32]  T. Nishihara,et al.  Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection , 1995, Infection and immunity.

[33]  D. Fine,et al.  Identification of Actinobacillus actinomycetemcomitans: polymerase chain reaction amplification of lktA-specific sequences. , 1993, Oral microbiology and immunology.

[34]  D. Case,et al.  Cell populations associated with active probing attachment loss. , 1992, Journal of periodontology.

[35]  S. Socransky,et al.  Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis. , 1988, The Journal of Periodontology.

[36]  D. Fine,et al.  Aggregatibacter actinomycetemcomitans-induced bone loss and antibody response in three rat strains. , 2011, Journal of periodontology.

[37]  D. Graves,et al.  Diabetic complications and dysregulated innate immunity. , 2008, Frontiers in bioscience : a journal and virtual library.

[38]  Louis C Gerstenfeld,et al.  Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. , 2004, Endocrinology.

[39]  K. Kojima,et al.  Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. , 1999, Archives of oral biology.

[40]  W. Knowler,et al.  Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. , 1998, Journal of periodontology.

[41]  L. Christersson.  Actinobacillus actinomycetemcomitans and localized juvenile periodontitis. Clinical, microbiologic and histologic studies. , 1993, Swedish dental journal. Supplement.

[42]  Christersson La.  Actinobacillus actinomycetemcomitans and localized juvenile periodontitis. Clinical, microbiologic and histologic studies. , 1993 .

[43]  W. Ketterl.  [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.